Case Report: Baricitinib as an Alternative in the Maintenance Therapy for Macrophage Activation Syndrome Secondary to Nodular Panniculitis

Case Report: Baricitinib as an Alternative in the Maintenance Therapy for Macrophage Activation Syndrome Secondary to Nodular Panniculitis

BackgroundMacrophage activation syndrome (MAS) is a severe complication of autoimmune diseases with high mortality. We report the effectiveness of baricitinib as an option for the maintenance therapy in MAS secondary to nodular panniculitis.Case summaryA 24-year-old female came to our hospital with...

Full description

Bibliographic Details
Main Authors: Guanqun Yi, Zhengping Huang, Zhixiang Huang, Yunqing Wang, Weiming Deng, Shaoling Zheng, Tianwang Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Immunology
Subjects:
baricitinib
macrophage activation syndrome
nodular panniculitis
maintenance therapy
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.914265/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.914265/full

Similar Items